ELEGEN

ELEGEN

生物技术

San Carlos,California 5,328 位关注者

Unlock the promise of synthetic biology by accelerating the Design-Build-Test-Learn cycle

关于我们

We are now at the dawn of the synthetic biology revolution, which will spawn new applications, markets, and business models, improving human lives in countless ways. This revolution will be driven by new technologies that enable DNA writing at speed and scale. To catalyze this revolution, Elegen is creating a suite of ground-breaking technologies to achieve DNA writing with unparalleled speed, cost, and quality. Elegen is unlocking the power to reprogram biology and create biologic solutions in order to solve some of humanity’s greatest challenges. Founded and led by Dr. Matthew Hill and located in San Carlos, CA, Elegen is a stealth-mode company that is well capitalized by top life science investors, including Andreessen Horowitz, 8VC, and KdT. The company is advised and staffed by leading biotechnology scientists and entrepreneurs, including Dr. Marc Unger, inventor of the Nanoflex? valve and former CSO of Fluidigm. Dr. Hill has a PhD from Stanford and a proven track record of advancing innovative technologies from invention to commercial success.

网站
https://www.elegenbio.com
所属行业
生物技术
规模
51-200 人
总部
San Carlos,California
类型
私人持股
创立
2017
领域
microfluidics、hardware、synthetic biology、engineering、organic chemsitry、DNA Synthesis、molecular biology和biology

地点

  • 主要

    1300 Industrial Rd

    US,California,San Carlos,94070

    获取路线

ELEGEN员工

动态

相似主页

查看职位

融资